|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2023―Sep―19 |
The role of Pannexin-1 channels, ATP, and purinergic receptors in the pathogenesis of HIV and SARS-CoV-2 |
Cristian A. Hernandez, Eliseo A. Eugenin |
2 |
[GO] |
2023―Mar―23 |
Purinergic signaling pathway in severe COVID-19 |
Lourdes Arruvito, Inés Sananez, Vanesa Seery, Constanza Russo, Jorge Geffner |
3 |
[GO] |
2022―May―08 |
COVID-19 therapy: from lung disease to systemic disorder |
Nora A. Fierro, Jesus Torres-Flores, Santiago Mirazo |
4 |
[GO] |
2022―May―02 |
Immunogenicity, breakthrough infection, and underlying disease flare after SARS-CoV-2 vaccination among individuals with systemic autoimmune rheumatic diseases |
Julie J. Paik, Jeffrey A. Sparks, Alfred H.J. Kim |
5 |
[GO] |
2022―Apr―14 |
COVID-19 and Retinal Degenerative Diseases: Promising link “Kaempferol” |
Arman Firoz, Priti Talwar |
6 |
[GO] |
2022―Feb―11 |
COVID-19 in Latin America and the Caribbean Region: Symptoms and Morbidities in the Epidemiology of Infection |
Julio Y. Anaya-Covarrubias, Antonio Pizuorno, Santiago Mirazo, Jesus Torres-Flores, Gisela Du Pont, Edmundo Lamoyi, Nora A. Fierro |
7 |
[GO] |
2021―Dec―31 |
Neuroinflammation in SARS-CoV2 infection: Pathogenesis and clinical manifestations |
Graciela Cárdenas, Gladis Fragoso, Edda Sciutto |
8 |
[GO] |
2021―Dec―21 |
Molecular Accuracy vs Antigenic Speed: SARS-CoV-2 Testing Strategies |
Álvaro Fajardo, Paula Perbolianachis, Irene Ferreiro, Pilar Moreno, Gonzalo Moratorio |
9 |
[GO] |
2021―Nov―22 |
Emerging mutations in the SARS-CoV-2 variants and their role in antibody escape to small molecule-based therapeutic resistance |
Chiranjib Chakraborty, Manojit Bhattacharya, Ashish Ranjan Sharma |
10 |
[GO] |
2021―Nov―18 |
Treatments for COVID-19: Lessons from 2020 and new therapeutic options |
Fanny Salasc, Thomas Lahlali, Emilie Laurent, Manuel Rosa-Calatrava, Andrés Pizzorno |
11 |
[GO] |
2021―Sep―27 |
Gastrointestinal manifestations and SARS-CoV-2 infection |
Antonio Pizuorno, Hassan Brim, Hassan Ashktorab |
12 |
[GO] |
2021―Aug―10 |
Updated pharmacological effects of Lonicerae japonicae flos, with a focus on its potential efficacy on coronavirus disease-2019 (COVID-19) |
Hui Zhao, Sha Zeng, Li Chen, Qiang Sun, Maolun Liu, Han Yang, et al. (+4) Shan Ren, Tianqi Ming, Xianli Meng, Haibo Xu |
13 |
[GO] |
2021―Apr―27 |
Organotypic human ex vivo models for COVID-19 research and drug development |
Sonia Youhanna, Shane C. Wright, Volker M. Lauschke |